Last update 31 Mar 2025

CagriSema

Overview

Basic Info

Drug Type
Recombinant polypeptide
Synonyms
Cagrilintide/Semaglutide, NN-9388
Action
agonists
Mechanism
AMYR agonists(Amylin receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 3
United States
01 Feb 2023
Diabetes Mellitus, Type 2Phase 3
Japan
01 Feb 2023
Diabetes Mellitus, Type 2Phase 3
Austria
01 Feb 2023
Diabetes Mellitus, Type 2Phase 3
Canada
01 Feb 2023
Diabetes Mellitus, Type 2Phase 3
Germany
01 Feb 2023
Diabetes Mellitus, Type 2Phase 3
Hungary
01 Feb 2023
Diabetes Mellitus, Type 2Phase 3
India
01 Feb 2023
Diabetes Mellitus, Type 2Phase 3
Ireland
01 Feb 2023
Diabetes Mellitus, Type 2Phase 3
Malaysia
01 Feb 2023
Diabetes Mellitus, Type 2Phase 3
Poland
01 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
vzukqnipqy(gdwsbxxwkg) = wcxvnhltog mfhejnihdf (wcdjyqkqxz )
Negative
10 Mar 2025
Placebo
vzukqnipqy(gdwsbxxwkg) = yrppisyllo mfhejnihdf (wcdjyqkqxz )
Not Applicable
-
-
zlullxugxz(ruchsxhewv) = zrhuxmfybe ulaiuapjmx (ctaqewhict )
Positive
03 Oct 2023
(Weight matched group (WM))
zlullxugxz(ruchsxhewv) = vhxtflubir ulaiuapjmx (ctaqewhict )
Not Applicable
-
-
Vehicle control
pglpvtmanr(pdcjqjcoen) = kahgwcanhv ibtwcvetaz (qgrdmdrnot )
-
21 Nov 2022
pglpvtmanr(pdcjqjcoen) = nyirelzhnm ibtwcvetaz (qgrdmdrnot )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free